Neuralink, a neurotech startup co-founded by Elon Musk, has received FDA approval for its first in-human clinical study to test its brain implant called the Link. The implant aims to help patients with severe paralysis regain the ability to control ext…

“Researchers have induced hibernation in a non-hibernating species (rats) with ultrasound, indicating the potential to do the same in humans with applications for medical trauma and spaceflight,” writes longtime Slashdot reader Baron_Yam. The research …

An anonymous reader quotes a report from the New York Times: Gert-Jan Oskam was living in China in 2011 when he was in a motorcycle accident that left him paralyzed from the hips down. Now, with a combination of devices, scientists have given him contr…

A study published in Nature Neuroscience suggests that brain signals can be used to detect the severity of chronic pain, potentially leading to the development of personalized therapies for individuals suffering from severe pain conditions. MIT Technol…

The World Health Organization (WHO) on Monday released guidance on non-sugar sweeteners (NSS), recommending against using them to control body weight. From the report: The recommendation is based on the findings of a systematic review of the available …

The Register reports:
AI algorithms can screen for pancreatic cancer and predict whether patients will develop the disease up to three years before a human doctor can make the same diagnosis, according to research published in Nature on Monday.

Pancr…

A personalized cancer vaccine made by BioNTech, the German company that produced the Pfizer-BioNTech COVID-19 vaccine, has shown promising results against pancreatic cancer. The vaccine, which teaches patients’ immune systems to attack their tumors, pr…

The World Health Organization ended the global emergency status for COVID-19 on Friday more than three years after its original declaration, and said countries should now manage the virus that killed more than 6.9 million people along with other infect…

An experimental Alzheimer’s medication slowed declines in patients’ ability to think clearly and perform daily tasks by more than a third in a large clinical trial, drugmaker Eli Lilly said Wednesday. From a report: Based on the results, in people with…